Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 30 % of short-term debt in 2025; threshold 65 %.
Financials
Financial year 2025
AK Herbo Pharma from Charleroi, company number BE0770728643, closed financial year 2025 with a result of € 61,600 after tax. For that financial year AK Herbo Pharma recorded a gross margin of € 112,500 and equity of € 466,258. Compared with financial year 2024, the result moved from € -18,337 to € 61,600. Profitable, and profit is growing. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on August 31, 2026.
€ 466,258
▲ 15% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 61,600
▲ still € 18,337 loss in 2024
Profit after tax over the fiscal year.
€ 2,500
▼ 77% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 391,258.
People and assets in 2025
0
Average over the fiscal year, from the social balance sheet.
€ 5
Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 3,705
▲ 192% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 1.8 million
▲ 5% vs 2024
€ 140,635 is repaid this year. At this pace the long-term loan is gone in ≈ 13 years.
€ 2,608
▲ 19% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 9,743
▲ 161% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 145,801 | € 38,334 | € 72,739 | € 112,500 | ▲ 55% |
| Profit after taxes | € 152,617 | € 90,468 | € -18,337 | € 61,600 | ▲ € 79,937 |
| Equity | € 334,616 | € 424,662 | € 404,658 | € 466,258 | ▲ 15% |
| Total debts | € 1,353,690 | € 1,294,004 | € 2,015,689 | € 2,124,818 | ▲ 5% |
| Cash | € 15,255 | € 4,521 | € 10,883 | € 2,500 | ▼ 77% |
| Land & buildings | - | - | € 694,382 | € 790,992 | ▲ 14% |
| Retained profit | € 259,616 | € 349,662 | € 329,658 | € 391,258 | ▲ 19% |
| Dividend | € 0 | € 0 | € 1,666 | € 0 | ▼ 100% |
| Bank debt | € 1,229,994 | € 1,155,694 | € 1,753,278 | € 1,836,732 | ▲ 5% |
| Balance sheet total | € 1,688,306 | € 1,718,666 | € 2,420,348 | € 2,591,076 | ▲ 7% |
Key figures of AK Herbo Pharma, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to AK Herbo Pharma?
What happened at AK Herbo Pharma in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 61,600. filed late Source: NBB ↗
- New establishment in Charleroi. KBO
- Start of the company according to the CBE. KBO
- ALI KASSEM became a director. NBB
- SANAE HAOUZI became a director. NBB
In short
From € 152,617 profit in 2022 to € 61,600 profit in 2025.
Paid € 64,754 in corporate taxes since 2022.
Best year ever: 2022, with € 152,617 profit.
Paid out € 1,666 in dividends to the owners in total.
A new publication or filing at AK Herbo Pharma? We notify you, reason included.
Follow AK Herbo PharmaDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind AK Herbo Pharma are ALI KASSEM and SANAE HAOUZI. It owns 100% of Millenium Pharma itself.
Directors
According to the 2025 annual accounts
since 2021
since 2021
Establishments
Establishment units
Physical locations of this company
Chaussée de Châtelet 5
6042 Charleroi
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0770.728.643
- VAT number
- BE 0770.728.643
- Registered office
- Chaussée de Châtelet 5, 6042 Charleroi
- Names & denominations
- AK Herbo Pharma
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 5 July 2021
- Peppol
- Active · Active since 11 Dec 2025
- Activities · NACE
Detailhandel in farmaceutische producten